Niagen Bioscience (NAGE) EBITDA (2010 - 2026)
Niagen Bioscience (NAGE) EBITDA from Jul 3, 2010 to Mar 31, 2026. The TTM Niagen Bioscience (NAGE) EBITDA is $14M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Niagen Bioscience (NAGE) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.66% |
Annual EBITDA change of Niagen Bioscience (NAGE)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $1.69M | -89.99% |
| 2025 | $17M | +101.31% |
| 2024 | $8.39M | -277.38% |
| 2023 | -$4.73M | -73.37% |
| 2022 | -$18M | -32.16% |
| 2021 | -$26M | +37.93% |
| 2020 | -$19M | -37.85% |
| 2019 | -$31M | -6.20% |
| 2018 | -$33M | +105.17% |
| 2017 | -$16M | +517.51% |
| 2016 | -$2.57M | N/A |
| 2015 | $0 | -100.00% |
| 2014 | -$660K | -84.06% |
| 2013 | -$4.14M | -63.40% |
| 2012 | -$11M | +50.00% |
| 2011 | -$7.54M | +550.00% |
| 2010 | -$1.16M | N/A |